High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Nodular Lymphocyte-Predominant Hodgkin Lymphoma

被引：33

作者：

Karuturi, Meghan ^{[1
]}

Hosing, Chitra ^{[1
]}

Fanale, Michelle ^{[2
]}

Medeiros, L. Jeffrey ^{[3
]}

Alousi, Amin M. ^{[1
]}

de Lima, Marcos J. ^{[1
]}

Qazilbash, Muzaffar H. ^{[1
]}

Kebriaei, Partow ^{[1
]}

Younes, Anas ^{[2
]}

Khouri, Issa ^{[1
]}

Andersson, Borje S. ^{[1
]}

Champlin, Richard ^{[1
]}

Anderlini, Paolo ^{[1
]}

Popat, Uday ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma, Houston, TX 77030 USA

[3] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA

来源：

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2013年 / 19卷 / 06期

关键词：

Hodgkin Lymphoma; Autologous stem cell transplantation; Nodular lymphocyte predominant Hodgkin lymphoma; Relapse; Chemosensitive; STUDY-GROUP GHSG; LONG-TERM; MARROW-TRANSPLANTATION; RITUXIMAB; PHASE-2; DISEASE; TRIAL;

D O I：

10.1016/j.bbmt.2013.03.008

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a distinct subtype of Hodgkin lymphoma that is characterized by unique clinical presentation, histological appearance, and indolent disease course. The recurrent nature of disease provides an opportunity to examine the role of stem cell transplantation in its management. We report here a single-center experience of 26 patients with relapsed NLPHL treated with high-dose chemotherapy and autologous stem cell transplantation between 1990 and 2008. With a median follow-up of 50 months (range, 2-138 months), the 5-year overall and event-free survival were 76% (SE 10%) and 69% (SE 10%), respectively. Our data suggest that high-dose chemotherapy and autologous transplantation should be considered as an option for patients with relapsed NLPHL. (C) 2013 American Society for Blood and Marrow Transplantation.

引用

页码：991 / 994

页数：4

共 50 条

[41] Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Special Type of (Follicular) B-Cell Lymphoma?
Carbone, Antonino
Gloghini, Annunziata
HEMATO, 2024, 5 (04): : 443 - 447
[42] Febrile cholestatic disease as an initial presentation of nodular lymphocyte-predominant Hodgkin lymphoma
Anna Mrzljak
Slavko Gasparov
Ika Kardum-Skelin
Vesna Colic-Cvrlje
Slobodanka Ostojic Kolonic
World Journal of Gastroenterology, 2010, 16 (35) : 4491 - 4493
[43] Febrile cholestatic disease as an initial presentation of nodular lymphocyte-predominant Hodgkin lymphoma
Mrzljak, Anna
Gasparov, Slavko
Kardum-Skelin, Ika
Colic-Cvrlje, Vesna
Ostojic-Kolonic, Slobodanka
WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (35) : 4491 - 4493
[44] "Popcorn cells" in intraoperative touch imprints of nodular lymphocyte-predominant Hodgkin lymphoma
Aragao, Alessa
Kilic, Irem
Velankar, Milind M.
Pambuccian, Stefan E.
DIAGNOSTIC CYTOPATHOLOGY, 2020, 48 (02) : 177 - 180
[45] High-dose therapy and autologous stem cell transplantation for chemoresistant Hodgkin lymphoma - The seattle experience
Gopal, Ajay K.
Metcalfe, Tracee L.
Gooley, Ted A.
Pagel, John M.
Petersdorf, Stephen H.
Bensinger, William I.
Holmberg, Leona
Maloney, David G.
Press, Oliver W.
CANCER, 2008, 113 (06) : 1344 - 1350
[46] Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) with CD30-positive lymphocyte-predominant (LP) cells
Seliem R.M.
Ferry J.A.
Hasserjian R.P.
Harris N.L.
Zukerberg L.R.
Journal of Hematopathology, 2011, 4 (3) : 175 - 181
[47] What Is the Appropriate Systemic Chemotherapy for Lymphocyte-Predominant Hodgkin's Lymphoma?
Mauch, Peter
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (01) : E8 - E8
[48] Cyclin D1 expression and polysomy in lymphocyte-predominant cells of nodular lymphocyte-predominant Hodgkin lymphoma
Cho, Benjamin B.
Kelting, Sarah M.
Gru, Alejandro A.
LeGallo, Robin D.
Pramoonjago, Patcharin
Goldin, Teresa A.
Heitz, Christopher T.
Aguilera, Nadine S.
ANNALS OF DIAGNOSTIC PATHOLOGY, 2017, 26 : 10 - 15
[49] Lymphocyte-predominant Hodgkin lymphoma: what is the optimal treatment?
Fanale, Michelle
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2013, : 406 - 413
[50] Relapsed nodular lymphocyte-predominant Hodgkin lymphoma presenting as severe paraneoplastic hepatitis: a case report
Deacon, Anthony J.
Goetz, Naeman N.
Weber, Nicholas
Clouston, Andrew
Gonsalkorala, Enoka
Baskerville, Catherine
Leggett, Barbara
JOURNAL OF MEDICAL CASE REPORTS, 2023, 17 (01)

← 1 2 3 4 5 →